Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.6K
Overview
45.6K
Immunological Memory01:23

Immunological Memory

7.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
7.8K
Development of Immunocompetence01:22

Development of Immunocompetence

482
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
482
Active versus Passive Immunity01:31

Active versus Passive Immunity

4.9K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
4.9K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

747
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
747
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.0K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination.

Open forum infectious diseases·2026
Same author

Discovery of a small molecule TLR3 agonist adjuvant.

Nature communications·2025
Same author

Performance of direct-from-blood culture bottle rapid phenotypic antimicrobial susceptibility testing for Gram-negative bacteremia at a children's hospital.

JAC-antimicrobial resistance·2025
Same author

Deep phenomics of PRR agonist activated human blood.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Prevalence of Cardiovascular Diseases in Young Human Immunodeficiency Virus-positive Patients in Western Uttar Pradesh.

The Journal of the Association of Physicians of India·2025
Same author

Incorporating meningeal immunity into vaccine development.

Nature communications·2025

Related Experiment Video

Updated: Oct 2, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.8K

Precision Vaccine Development: Cues From Natural Immunity.

Soumik Barman1,2, Dheeraj Soni1,2, Byron Brook1,2

  • 1Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.

Frontiers in Immunology
|February 28, 2022
PubMed
Summary

Developing effective vaccines requires mimicking natural infection immunity. Understanding immune responses and pathogenesis is key for next-generation infectious disease vaccines.

Keywords:
adaptive immunityadjuvantsantigensimmune systeminnate immunitynatural infectionvaccinesvita-PAMP

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Related Experiment Videos

Last Updated: Oct 2, 2025

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

3.8K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.9K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Traditional vaccine development aims for antibody and cellular responses correlating with protection.
  • This approach is partially effective as vaccine-induced immunity may not fully overlap with pathogen-specific immunity.
  • Mimicking natural infection's immune response is a promising strategy for improved vaccine efficacy.

Purpose of the Study:

  • To review recent advances in vaccine development.
  • To highlight the importance of understanding immune responses to natural infections.
  • To inform the next generation of infectious disease vaccines.

Main Methods:

  • Review of current literature on vaccine development and immunology.
  • Analysis of differences between immunizing and non-immunizing immune responses.
  • Examination of immune ontogeny shifts during natural infections.

Main Results:

  • Current vaccine strategies may not perfectly replicate natural immunity.
  • Gaps in understanding human immunity and pathogenesis hinder optimal vaccine design.
  • Differences in immune responses to natural infections offer insights for vaccine improvement.

Conclusions:

  • Next-generation vaccines should better mimic natural infection's immune profile.
  • Understanding immune ontogeny and response variations is crucial for vaccine advancement.
  • Further research into human immunity and pathogenesis is vital for developing more effective vaccines.